Joan Hecht

2.4k total citations · 3 hit papers
10 papers, 1.8k citations indexed

About

Joan Hecht is a scholar working on Epidemiology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Joan Hecht has authored 10 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 5 papers in Surgery and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Joan Hecht's work include Liver Disease Diagnosis and Treatment (8 papers), Pancreatitis Pathology and Treatment (5 papers) and Diet, Metabolism, and Disease (3 papers). Joan Hecht is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Pancreatitis Pathology and Treatment (5 papers) and Diet, Metabolism, and Disease (3 papers). Joan Hecht collaborates with scholars based in United States, Argentina and Israel. Joan Hecht's co-authors include Romina Lomonaco, Beverly Orsak, Kenneth Cusi, Fernando Bril, Amy Webb, Fermin O. Tio, Paola Portillo-Sánchez, Carolina Ortiz‐Lopez, Jean Hardies and Nicolas Musi and has published in prestigious journals such as Annals of Internal Medicine, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Joan Hecht

10 papers receiving 1.7k citations

Hit Papers

Long-Term Pioglitazone Treatment for Patients With Nonalc... 2015 2026 2018 2022 2016 2015 2019 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
    2016 737 citations Kenneth Cusi, Beverly Orsak et al. Annals of Internal Medicine profile →
  2. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
    2015 393 citations Paola Portillo-Sánchez, Fernando Bril et al. The Journal of Clinical Endocrinology & Metabolism profile →
  3. Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
    2019 235 citations Fernando Bril, Diane Biernacki et al. Diabetes Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joan Hecht United States 8 1.6k 1.0k 549 339 321 10 1.8k
Paola Portillo-Sánchez United States 10 1.5k 1.0× 1.0k 1.0× 436 0.8× 355 1.0× 336 1.0× 12 1.8k
Russell Havranek United States 3 1.2k 0.7× 789 0.8× 332 0.6× 362 1.1× 244 0.8× 5 1.4k
Sunil Kumar Dwivedi India 3 1.2k 0.7× 790 0.8× 331 0.6× 363 1.1× 239 0.7× 8 1.4k
Geoff Farrell Australia 11 1.2k 0.8× 490 0.5× 516 0.9× 310 0.9× 216 0.7× 15 1.5k
Diane Biernacki United States 8 1.2k 0.8× 737 0.7× 368 0.7× 207 0.6× 238 0.7× 9 1.4k
Ramy Younes Italy 15 1.1k 0.7× 534 0.5× 422 0.8× 212 0.6× 183 0.6× 37 1.3k
John Willy Haukeland Norway 12 1.0k 0.7× 444 0.4× 334 0.6× 279 0.8× 212 0.7× 21 1.3k
M Pérez-Carreras Spain 8 927 0.6× 400 0.4× 205 0.4× 401 1.2× 129 0.4× 21 1.2k
Maria Antonella Burza Sweden 15 665 0.4× 401 0.4× 240 0.4× 106 0.3× 252 0.8× 21 985
M. Krausch Germany 15 799 0.5× 458 0.4× 232 0.4× 371 1.1× 332 1.0× 34 1.4k

Countries citing papers authored by Joan Hecht

Since Specialization
Citations

This map shows the geographic impact of Joan Hecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Hecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Hecht more than expected).

Fields of papers citing papers by Joan Hecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan Hecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Hecht. The network helps show where Joan Hecht may publish in the future.

Co-authorship network of co-authors of Joan Hecht

This figure shows the co-authorship network connecting the top 25 collaborators of Joan Hecht. A scholar is included among the top collaborators of Joan Hecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan Hecht. Joan Hecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bril, Fernando, Diane Biernacki, Srilaxmi Kalavalapalli, et al.. (2019). Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care. 42(8). 1481–1488. 235 indexed citations breakdown →
2.
Bril, Fernando, Diane Biernacki, Romina Lomonaco, et al.. (2018). Role of Vitamin E for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients with T2DM—A Randomized, Controlled Trial. Diabetes. 67(Supplement_1). 3 indexed citations
3.
Bril, Fernando, Romina Lomonaco, Beverly Orsak, et al.. (2017). Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial. The Journal of Clinical Endocrinology & Metabolism. 102(8). 2950–2961. 75 indexed citations
4.
Cusi, Kenneth, Beverly Orsak, Fernando Bril, et al.. (2016). Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus. Annals of Internal Medicine. 14 indexed citations
5.
Cusi, Kenneth, Beverly Orsak, Fernando Bril, et al.. (2016). Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus. Annals of Internal Medicine. 165(5). 305–315. 737 indexed citations breakdown →
6.
Portillo-Sánchez, Paola, Fernando Bril, Maryann Maximos, et al.. (2015). High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels. The Journal of Clinical Endocrinology & Metabolism. 100(6). 2231–2238. 393 indexed citations breakdown →
7.
Bril, Fernando, Romina Lomonaco, Beverly Orsak, et al.. (2013). Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis. Hepatology. 59(6). 2178–2187. 128 indexed citations
8.
Cusi, Kenneth, Zhihui Chang, Romina Lomonaco, et al.. (2013). Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. Journal of Hepatology. 60(1). 167–174. 193 indexed citations
9.
Hecht, Joan, J.M. Dellacha, J.A. Santomé, et al.. (1972). Lipolytic activity of bovine growth hormone bound to sepharose beads. FEBS Letters. 20(1). 83–86. 11 indexed citations
10.
Peña‐Diaz, Priscila, Joan Hecht, J.A. Santomé, J.M. Dellacha, & Antonella Paladini. (1972). Unspecificity of the tibia‐test for growth hormone assay Methyl thiocyanate: An interfering substance. FEBS Letters. 27(2). 338–340. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paola Portillo-Sánchez Breakdown of academic impact, for papers by Russell Havranek Breakdown of academic impact, for papers by Sunil Kumar Dwivedi Breakdown of academic impact, for papers by Geoff Farrell Breakdown of academic impact, for papers by Diane Biernacki Breakdown of academic impact, for papers by Ramy Younes Breakdown of academic impact, for papers by John Willy Haukeland Breakdown of academic impact, for papers by M Pérez-Carreras Breakdown of academic impact, for papers by Maria Antonella Burza Breakdown of academic impact, for papers by M. Krausch
Rankless by CCL
2026